Product image of Glukóz Teva (Glucose Monohydrate) supplied by GNH India

Glukóz Teva

Active Ingredient:
Glucose Monohydrate
Origin:
EU

Glukóz Teva (Glucose Monohydrate)

Glukóz Teva is an intravenous solution that contains glucose monohydrate as its active ingredient. It is supplied in a sterile liquid form for infusion into the bloodstream. The product is manufactured for the European Union market and is used to provide a rapid source of glucose for metabolic needs. Glukóz Teva is typically packaged in single‑use containers suitable for hospital and clinical settings.

Manufacturer / TM Owner

Teva Gyógyszergyár Zrt

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glukóz Teva is administered intravenously to address acute or temporary needs for glucose. It is commonly employed in the following clinical situations:

  • Treatment of hypoglycaemia when oral glucose is not feasible.
  • Provision of caloric support during peri‑operative fasting.
  • Management of metabolic demands in critically ill patients.
  • Support during prolonged intravenous nutrition regimens.
  • Stabilisation of blood glucose levels in patients receiving insulin therapy.
  • Adjunct therapy in certain diagnostic procedures requiring glucose infusion.

Side Effects

Glukóz Teva may cause a range of reactions, most of which are related to the rapid increase in plasma glucose. These effects are generally classified as follows:

Common

  • Transient hyperglycaemia.
  • Local irritation at the infusion site.
  • Mild nausea or abdominal discomfort.
  • Headache associated with rapid glucose shifts.

Serious

  • Severe hyperglycaemia leading to osmotic diuresis.
  • Electrolyte imbalances, particularly hyponatraemia.
  • Allergic reactions such as rash or urticaria.
  • Volume overload in patients with compromised cardiac function.

Precautions & Warnings

When using Glukóz Teva, healthcare professionals should consider several safety measures to minimise risk:

  • Verify patient’s blood glucose level before administration.
  • Adjust infusion rate in patients with diabetes or impaired glucose tolerance.
  • Monitor electrolytes, especially sodium and potassium, during prolonged use.
  • Use caution in patients with renal or cardiac insufficiency due to fluid volume concerns.
  • Ensure aseptic technique to prevent contamination of the intravenous line.
  • Review medication history for agents that may potentiate hyperglycaemia.

Avoid Interactions

Glukóz Teva can interact with other medications, requiring careful assessment:

Avoid

  • Concurrent high‑dose insulin therapy without glucose monitoring.
  • Co‑administration with sulfonylureas in patients prone to hypoglycaemia.

Use with caution

  • Beta‑blockers, which may mask hypoglycaemia symptoms.
  • Corticosteroids, which can increase glucose production.
  • Diuretics that affect electrolyte balance.
  • Medications that cause fluid retention, such as certain antihypertensives.

Frequently Asked Questions

Glukóz Teva provides a rapid source of glucose to raise plasma glucose levels and meet immediate metabolic needs, especially when oral intake is not possible.

It is commonly used for treating hypoglycaemia, supporting patients during peri‑operative fasting, providing caloric support in critical care, and as part of total parenteral nutrition regimens.

Blood glucose should be measured before starting the infusion and regularly during administration to adjust the rate and avoid hyperglycaemia or hypoglycaemia.

Yes, but the infusion rate must be carefully controlled and glucose levels closely monitored to prevent excessive rises in blood sugar.

Common side effects include transient hyperglycaemia, mild nausea, headache, and local irritation at the infusion site.

Serious reactions can include severe hyperglycaemia, electrolyte disturbances, allergic skin reactions, and fluid overload in patients with heart failure.

There are no absolute contraindications listed, but caution is advised in patients with uncontrolled diabetes, severe renal or cardiac impairment, and known hypersensitivity to glucose solutions.

Concurrent high‑dose insulin can cause rapid drops in blood glucose; therefore, insulin dosing should be adjusted and glucose levels monitored when both are used.

Diuretics can affect electrolyte balance, so electrolytes should be monitored and the infusion rate of Glukóz Teva may need adjustment.

Glukóz Teva can be used in pediatric care, but dosing and infusion rates must be determined by a qualified healthcare professional based on weight and clinical condition.

The solution should be stored at controlled room temperature, protected from light, and used before the expiration date indicated on the packaging.

Mixing should only be done according to institutional protocols; incompatibilities may exist, so separate lines are often preferred.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Glucose Monohydrate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT